Brochure
13 Jun 2023

SINOVAC Vaccines leaflets

PDF 5.5 MB
Download

Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases.

SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, and mumps.

Content provided by our supplier

Sinovac Biotech Ltd.

  • CN
  • 2018
    On CPHI since
  • 2
    Certificates
  • 1000 - 4999
    Employees
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Clinical Research
View company profile

Other Content from Sinovac Biotech Ltd. (1)

  • SINOVAC Named BogotáBio Exclusive Partner, Fueling New Vaccine Advances in Colombia

    News SINOVAC Named BogotáBio Exclusive Partner, Fueling New Vaccine Advances in Colombia

    Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced it has been named the exclusive strategic partner of BogotáBio, which will break ground as the first local human vaccine production facility to be established in Colombia’s capital city of Bogota.

    14 Jul 2021